133 related articles for article (PubMed ID: 31606842)
1. Idiopathic anaphylaxis and systemic mastocytosis.
Francischetti IMB; Maric I
Int J Hematol; 2019 Dec; 110(6):643-644. PubMed ID: 31606842
[No Abstract] [Full Text] [Related]
2. High prevalence of anaphylaxis in patients with systemic mastocytosis - a single-centre experience.
Gülen T; Hägglund H; Dahlén B; Nilsson G
Clin Exp Allergy; 2014 Jan; 44(1):121-9. PubMed ID: 24164252
[TBL] [Abstract][Full Text] [Related]
3. [IgE mediated anaphylaxis in a patient with systemic mastocytosis].
Escande H; Bennani I; Bulai Livideanu C; Uthurriague C; Paul C; Nougué J
Ann Dermatol Venereol; 2013 Oct; 140(10):641-4. PubMed ID: 24090896
[TBL] [Abstract][Full Text] [Related]
4. Myelomastocytic leukemia versus mast cell leukemia versus systemic mastocytosis associated with acute myeloid leukemia: a diagnostic challenge.
Arredondo AR; Gotlib J; Shier L; Medeiros B; Wong K; Cherry A; Corless C; Arber DA; Valent P; George TI
Am J Hematol; 2010 Aug; 85(8):600-6. PubMed ID: 20658589
[No Abstract] [Full Text] [Related]
5. Fatal bleeding due to a heparin-like anticoagulant in a 37-year-old woman suffering from systemic mastocytosis.
Sucker C; Mansmann G; Steiner S; Gattermann N; Schmitt-Graeff A; Loncar R; Scharf RE; Stockschlader M
Clin Appl Thromb Hemost; 2008 Jul; 14(3):360-4. PubMed ID: 18160568
[TBL] [Abstract][Full Text] [Related]
6. [Sudden death in the presence of systemic mastocytosis and urticaria pigmentosa].
Wehner F; Wehner HD; Fritz P; Benz D; Schulz MM
Arch Kriminol; 2008; 222(5-6):187-94. PubMed ID: 19216369
[TBL] [Abstract][Full Text] [Related]
7. Isolated bone marrow mastocytosis: an underestimated subvariant of indolent systemic mastocytosis.
Zanotti R; Bonadonna P; Bonifacio M; Artuso A; Schena D; Rossini M; Perbellini O; Colarossi S; Chilosi M; Pizzolo G
Haematologica; 2011 Mar; 96(3):482-4. PubMed ID: 21193416
[No Abstract] [Full Text] [Related]
8. Systemic mastocytosis with an associated clonal hematologic non-mast cell lineage disease (SM-AHNMD) in an infant patient.
Kawakami T; Haga T; Soma Y; Nagae C; Kinoshita A
J Dermatol; 2014 Aug; 41(8):761-3. PubMed ID: 25099159
[No Abstract] [Full Text] [Related]
9. Management around invasive procedures in mastocytosis: An update.
Hermans MAW; Arends NJT; Gerth van Wijk R; van Hagen PM; Kluin-Nelemans HC; Oude Elberink HNG; Pasmans SGMA; van Daele PLA
Ann Allergy Asthma Immunol; 2017 Oct; 119(4):304-309. PubMed ID: 28866309
[TBL] [Abstract][Full Text] [Related]
10. Tryptase detection in bone-marrow blood: a new diagnostic tool in systemic mastocytosis.
Proelss J; Wenzel J; Ko Y; Bieber T; Bauer R
J Am Acad Dermatol; 2007 Mar; 56(3):453-7. PubMed ID: 17317486
[TBL] [Abstract][Full Text] [Related]
11. A distinct biomolecular profile identifies monoclonal mast cell disorders in patients with idiopathic anaphylaxis.
Carter MC; Desai A; Komarow HD; Bai Y; Clayton ST; Clark AS; Ruiz-Esteves KN; Long LM; Cantave D; Wilson TM; Scott LM; Simakova O; Jung MY; Hahn J; Maric I; Metcalfe DD
J Allergy Clin Immunol; 2018 Jan; 141(1):180-188.e3. PubMed ID: 28629749
[TBL] [Abstract][Full Text] [Related]
12. Assessment of clinical findings, tryptase levels, and bone marrow histopathology in the management of pediatric mastocytosis.
Carter MC; Clayton ST; Komarow HD; Brittain EH; Scott LM; Cantave D; Gaskins DM; Maric I; Metcalfe DD
J Allergy Clin Immunol; 2015 Dec; 136(6):1673-1679.e3. PubMed ID: 26044856
[TBL] [Abstract][Full Text] [Related]
13. Systemic mastocytosis presenting as IgE-mediated food-induced anaphylaxis: A report of two cases.
Prieto-García A; Álvarez-Perea A; Matito A; Sánchez-Muñoz L; Morgado JM; Escribano L; Álvarez-Twose I
J Allergy Clin Immunol Pract; 2015; 3(3):456-8. PubMed ID: 25687289
[No Abstract] [Full Text] [Related]
14. Safety and effectiveness of immunotherapy in patients with indolent systemic mastocytosis presenting with Hymenoptera venom anaphylaxis.
González de Olano D; Alvarez-Twose I; Esteban-López MI; Sánchez-Muñoz L; de Durana MD; Vega A; García-Montero A; González-Mancebo E; Belver T; Herrero-Gil MD; Fernández-Rivas M; Orfao A; de la Hoz B; Castells MC; Escribano L
J Allergy Clin Immunol; 2008 Feb; 121(2):519-26. PubMed ID: 18177694
[TBL] [Abstract][Full Text] [Related]
15. Altered apoptosis and cell cycling of mast cells in bone marrow lesions of patients with systemic mastocytosis.
Baldus SE; Zirbes TK; Thiele J; Eming SA; Henz BM; Hartmann K
Haematologica; 2004 Dec; 89(12):1525-7. PubMed ID: 15590405
[TBL] [Abstract][Full Text] [Related]
16. [New views on systemic mastocytosis].
Pluta A; Gutkowski K
Pol Merkur Lekarski; 2003 Feb; 14(80):159-62. PubMed ID: 12728681
[TBL] [Abstract][Full Text] [Related]
17. Systemic Mastocytosis: documented pathologic response to imatinib.
Gollard RP; Ruemmler-Fish C; Garcia D
Eur J Haematol; 2007 Oct; 79(4):367-8. PubMed ID: 17655701
[No Abstract] [Full Text] [Related]
18. Indolent systemic mastocytosis with elevated serum tryptase, absence of skin lesions, and recurrent severe anaphylactoid episodes.
Florian S; Krauth MT; Simonitsch-Klupp I; Sperr WR; Fritsche-Polanz R; Sonneck K; Födinger M; Agis H; Böhm A; Wimazal F; Horny HP; Valent P
Int Arch Allergy Immunol; 2005 Mar; 136(3):273-80. PubMed ID: 15722637
[TBL] [Abstract][Full Text] [Related]
19. Systemic mastocytosis associated with chronic idiopathic myelofibrosis: a distinct subtype of systemic mastocytosis associated with a [corrected] clonal hematological non-mast [corrected] cell lineage disorder carrying the activating point mutations KITD816V and JAK2V617F.
Sotlar K; Bache A; Stellmacher F; Bültmann B; Valent P; Horny HP
J Mol Diagn; 2008 Jan; 10(1):58-66. PubMed ID: 18165278
[TBL] [Abstract][Full Text] [Related]
20. IgE-mediated anaphylaxis to Hippobosca equina in a patient with systemic mastocytosis.
Matito A; Bartolomé-Zavala B; Alvarez-Twose I; Sánchez-Matas I; Escribano L
Allergy; 2010 Aug; 65(8):1058-9. PubMed ID: 20002662
[No Abstract] [Full Text] [Related]
[Next] [New Search]
